Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
Roche BTK inhibitor may show 'holy grail' of brain penetration
Roche has claimed the latest phase 2 readout for its multiple sclerosis drug backs up the BTK inhibitor’s “best in disease” potential.
James Waldron
Oct 13, 2023 9:30am
Roche pays $70M for HER2 breast cancer brain metastases prospect
May 9, 2023 6:30am
Blood-brain barrier no barrier to diabetes drugs in Alzheimer's
Oct 27, 2022 3:10pm
Bioasis, Neuramedy sign blood-brain barrier pact for $72M
May 11, 2022 10:55am
Sanofi makes $75M preclinical bet to join busy Parkinson's field
Jan 12, 2022 8:45am
Emulate's brain models head to space to study gravity's effects
Dec 29, 2021 8:41am